These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4377076)

  • 21. [Dynamic investigations of pituitary function in patients with chromophobe pituitary adenoma or with acromegaly].
    Muhlbauer MA; Ruedi B; Lemarchand-Beraud T; Buber B; Aubert M; Felber JP
    Ann Endocrinol (Paris); 1972; 33(4):440-6. PubMed ID: 4351896
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)].
    Silvestrini F; Liuzzi A; Chiodini PG; Cattabeni A; Botalla L
    Folia Endocrinol; 1973 Oct; 26(5):398-406. PubMed ID: 4203133
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypothalamic releasing factors.
    Burgus R; Guillemin R
    Annu Rev Biochem; 1970; 39():499-526. PubMed ID: 4320674
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.
    Marcovitz S; Goodyer CG; Guyda H; Gardiner RJ; Hardy J
    J Clin Endocrinol Metab; 1982 Jan; 54(1):6-16. PubMed ID: 6119321
    [No Abstract]   [Full Text] [Related]  

  • 25. Variation of pituitary thyrotropin reserve with different dosages of thyrotropin-releasing hormine (TRH) -- mode of failure of pituitary thyrotropin reserve.
    Sakoda M; Mori H; Tateiwa M; Kusaka T; Fukuda T
    Kobe J Med Sci; 1976 Jun; 22(2):81-9. PubMed ID: 827655
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pituitary adenomas. Surgical treatment by transphenoidal approach].
    Somma M; Rasio E; Beauregard H; Hardy J
    Union Med Can; 1980 Jan; 109(1):68-81. PubMed ID: 6247803
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuroendocrine relationships.
    Van Loon GR; Kragt CL
    Prog Neurol Psychiatry; 1971; 26():261-310. PubMed ID: 4363627
    [No Abstract]   [Full Text] [Related]  

  • 28. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients.
    Cohen R; Bouquier D; Biot-Laporte S; Vermeulen E; Claustrat B; Cherpin MH; Cabrera P; Guidetti P; Ferry S; Bizollon CA
    J Clin Endocrinol Metab; 1986 May; 62(5):892-8. PubMed ID: 3007559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modern methods for ambulatory evaluation of hypothalamic-pituitary function].
    Staub JJ; Noelpp B
    Ther Umsch; 1979 Oct; 36(10):855-66. PubMed ID: 231333
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
    Suda T; Tomori N; Tozawa F; Demura H; Shizume K
    J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The response to TRH, LH-RH, metyrapone and vasopressin in patients with hypothalamo-pituitary disorders.
    Lundberg PO; Wide L
    Eur J Clin Invest; 1973 Jan; 3(1):49-56. PubMed ID: 4347096
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.
    Lloyd RV; Wilson BS; Kovacs K; Ryan N
    Arch Pathol Lab Med; 1985 Jun; 109(6):515-7. PubMed ID: 2986572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadal function in fifty men with untreated pituitary adenomas.
    Snyder PJ; Bigdeli H; Gardner DF; Mihailovic V; Rudenstein RS; Sterling FH; Utiger RD
    J Clin Endocrinol Metab; 1979 Feb; 48(2):309-14. PubMed ID: 218986
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.
    Wehrenberg WB; Baird A; Ying SY; Rivier C; Ling N; Guillemin R
    Endocrinology; 1984 Jun; 114(6):1995-2001. PubMed ID: 6327231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ESTIMATION OF THYROSTIMULIN RESERVES BY THE NEO-MERCAZOLE TEST].
    LINQUETTE M; SWYNGEDAUW J; FOSSATI P; MAY JP; GASNAULT JP
    Ann Endocrinol (Paris); 1963; 24():1008-14. PubMed ID: 14098075
    [No Abstract]   [Full Text] [Related]  

  • 36. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plurihormonal pituitary adenomas.
    Scheithauer BW; Horvath E; Kovacs K; Laws ER; Randall RV; Ryan N
    Semin Diagn Pathol; 1986 Feb; 3(1):69-82. PubMed ID: 3039632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An FSH-producing pituitary tumor in a patient with hypogonadism.
    Woolf PD; Schenk EA
    J Clin Endocrinol Metab; 1974 Apr; 38(4):561-8. PubMed ID: 4362394
    [No Abstract]   [Full Text] [Related]  

  • 39. Fine structural features of secretion in adenomas of human pituitary gland.
    Ryder DR; Horvath E; Kovacs K
    Arch Pathol Lab Med; 1980 Oct; 104(10):518-22. PubMed ID: 6774693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone secretion in pituitary disease.
    Nelson JC; Kollar DJ; Lewis JE
    Arch Intern Med; 1974 Mar; 133(3):459-63. PubMed ID: 4811484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.